Abundance Wealth Counselors’s 10x Genomics TXG Stock Holding History

Abundance Wealth Counselors’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$686K	Buy	17,882 +8,406	+89%	+$220K	0.04%	156
2026 Q1	$201K	Buy	+9,476	New	+$189K	0.03%	235
2024 Q2	–	Sell	-7,467	Closed	-$280K	–	141
2024 Q1	$280K	Hold	7,467	–	–	0.06%	121
2023 Q4	$418K	Hold	7,467	–	–	0.11%	106
2023 Q3	$308K	Hold	7,467	–	–	0.09%	109
2023 Q2	$417K	Hold	7,467	–	–	0.22%	49
2023 Q1	$417K	Buy	7,467 +1,024	+16%	+$47.8K	0.11%	107
2022 Q4	$235K	Buy	+6,443	New	+$211K	0.06%	129
2022 Q3	–	Sell	-5,901	Closed	-$267K	–	144
2022 Q2	$267K	Hold	5,901	–	–	0.07%	120
2022 Q1	$449K	Hold	5,901	–	–	0.12%	96
2021 Q4	$879K	Hold	5,901	–	–	0.23%	61
2021 Q3	$859K	Hold	5,901	–	–	0.5%	24
2021 Q2	$1.16M	Buy	5,901 +1,178	+25%	+$213K	0.3%	47
2021 Q1	$855K	Hold	4,723	–	–	0.21%	55
2020 Q4	$669K	Buy	4,723 +1,574	+50%	+$228K	0.17%	59
2020 Q3	$393K	Buy	+3,149	New	+$331K	0.11%	68

Other funds holding TXG

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Caprock Group Boise, Idaho $5.22B AUM 42.47% 1-Year Est. Return

Financial Consulate Hunt Valley, Maryland $899M AUM 20.23% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return

CPC

Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return

MCP

Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return

BEI

Benjamin Edwards Inc Clayton, Missouri $11B AUM 18.22% 1-Year Est. Return

AWA

Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Abundance Wealth Counselors's TXG Position: Q2 2026 in Review

Abundance Wealth Counselors increased its 10x Genomics (TXG) stake by 89% in Q2 2026, buying an estimated $220K and bringing the position to 17,882 shares worth $686K. The position accounts for 0.04% of the portfolio, ranked #156.

Abundance Wealth Counselors first reported a position in TXG in Q3 2020 and has held it in 16 quarters since. The position peaked at $1.16M in Q2 2021. 70 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

Abundance Wealth Counselors held 17,882 shares of 10x Genomics worth $686K as of Q2 2026.
Abundance Wealth Counselors bought 8,406 10x Genomics shares in Q2 2026, an estimated $220K.
10x Genomics made up 0.04% of Abundance Wealth Counselors's portfolio in Q2 2026, its #156 holding.
Abundance Wealth Counselors first reported a position in 10x Genomics in Q3 2020 and has held it in 16 quarters since.
Abundance Wealth Counselors's 10x Genomics position peaked at $1.16M in Q2 2021.
70 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Abundance Wealth Counselors's 13F filing for Q2 2026, filed 23 Jul 2026.